Reumatoloxía

2023

1. Classifying extracranial large-vessel giant cell arteritis using the new 2022 American College of Rheumatology/EULAR classification criteria: comment on the article by Ponte et al

   Arthritis and Rheumatology

2. Co-occurrence of giant cell arteritis in patients with polymyalgia rheumatica. Comment on the article by Nielsen AW, et al

   Seminars in Arthritis and Rheumatism

3. Polymyalgia rheumatica: when should we suspect an underlying large vessel vasculitis?

   Clinical and experimental rheumatology

4. Reply to comment on: Alpha-Klotho protein in systemic lupus erythematosus

   Clinical and experimental rheumatology

5. Reply to: New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. by Guarda et al

   Clinical and experimental rheumatology

6. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: Results from the COVID-19 Global Rheumatology Alliance physician reported registry' by Arnaud and Devilliers

   Annals of the Rheumatic Diseases

7. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: Results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Mulhearn et al

   Annals of the Rheumatic Diseases

8. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Rosenbaum et al

   Annals of the Rheumatic Diseases

9. Skin lesions, arthritis, chondritis, and cytopenias

   Leukemia

10. The genetic contribution of inflammation to the increased risk of cardiovascular disease in rheumatoid arthritis: comment on the article by Yuan et al

    Arthritis and Rheumatology